Wells Fargo
ELOS

Wells Fargo’s Syneron Medical Ltd ELOS Stock Holding History

Wells Fargo’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-738
Closed -$8K – 6679
2017
Q2 		$8K Sell
738
-138
-16% -$1.51K ﹤0.01% 5838
2017
Q1 		$9K Buy
876
+145
+20% +$1.4K ﹤0.01% 5915
2016
Q4 		$6K Buy
731
+138
+23% +$1.08K ﹤0.01% 5934
2016
Q3 		$4K Hold
593
– – ﹤0.01% 5977
2016
Q2 		$5K Hold
593
– – ﹤0.01% 5831
2016
Q1 		$4K Hold
593
– – ﹤0.01% 5940
2015
Q4 		$5K Hold
593
– – ﹤0.01% 5892
2015
Q3 		$4K Buy
593
+291
+96% +$2.8K ﹤0.01% 5916
2015
Q2 		$3K Hold
302
– – ﹤0.01% 6131
2015
Q1 		$4K Hold
302
– – ﹤0.01% 5885
2014
Q4 		$3K Sell
302
-2,300
-88% -$22.2K ﹤0.01% 5979
2014
Q3 		$26K Buy
2,602
+2,300
+762% +$23.4K ﹤0.01% 5197
2014
Q2 		$3K Sell
302
-80
-21% -$865 ﹤0.01% 5916
2014
Q1 		$5K Sell
382
-100
-21% -$1.19K ﹤0.01% 5567
2013
Q4 		$6K Sell
482
-6,047
-93% -$62.8K ﹤0.01% 5331
2013
Q3 		$56K Buy
6,529
+1
+0% +$9 ﹤0.01% 4643
2013
Q2 		$56K Buy
+6,528
New +$58.4K ﹤0.01% 4581

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Wells Fargo's ELOS Position: Q3 2017 in Review

Wells Fargo sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 738 shares — an estimated $8K sold.

Wells Fargo first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $56K in Q3 2013. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Wells Fargo reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Wells Fargo sold 738 Syneron Medical Ltd shares in Q3 2017, an estimated $8K.
  • Wells Fargo first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
  • Wells Fargo's Syneron Medical Ltd position peaked at $56K in Q3 2013.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Wells Fargo's 13F filing for Q3 2017, filed 9 Nov 2017.